Press Releases

Active Biotech: Interim report January - March 2017
April 27, 2017 08:30 (CEST)
Regulatory
Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for the treatment of multiple myeloma
April 12, 2017 13:30 (CEST)
Regulatory
Active Biotech AB Year-end report January - December 2016
February 16, 2017 08:30 (CET)
Regulatory
The European Patent Office grants patent for tasquinimod for treatment of multiple myeloma
January 9, 2017 13:00 (CET)
Regulatory
Number of shares and votes in Active Biotech
December 30, 2016 08:30 (CET)
Active Biotech's rights issue completed
December 12, 2016 17:31 (CET)
Active Biotech's election committee appointed
November 22, 2016 15:05 (CET)
Prospectus relating to Active Biotech's rights issue published
November 18, 2016 15:16 (CET)
Active Biotech carries out rights issue
November 11, 2016 19:13 (CET)
Active Biotech AB Interim report January - September 2016
November 11, 2016 19:00 (CET)